Updated at 5:25 p.m.
Senate and House lawmakers unveiled legislation Tuesday that would require brand-name drugmakers to pay rebates to Medicare for drugs used by some of the program’s low-income and disabled beneficiaries.
- Click to share on X (Opens in new window) X
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to email a link to a friend (Opens in new window) Email
- Click to print (Opens in new window) Print
- Republish This Story
Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.